'Buy' Sun Pharma, Cipla; 'Hold' Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results

Systematix expects select companies in the US to benefit from the ramp up in generic Revlimid like Zydus Life and Sun Pharmaceuticals.